Annual Lung SPORE Workshop (Abstract Submission)

76 submissions
Created First Name Last Name Email Phone Select a Session Topic Abstract Title First Author First Name First Author Last Name Affiliation List of Additional Authors Your Abstract Submission Upload Abstract Special Characters Included? Abstract Review Status Upload Poster Poster Uploaded Operations
Wed, 04/03/2024 - 17:40 Cecil Han ch1182@georgetown.edu 2026878634 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies The emerging role of deubiquitinating enzyme USP13 in lung cancer plasticity Juntae Kwon Georgetown University School of Medicine Abstract_Submission.pdf No
Sun, 03/31/2024 - 18:56 Loretta Erhunmwunsee lorettae@coh.org 6262187287 Session 2: Health Disparities in Lung Cancer Reducing Racial Residential Segregation Lowers the Risk of Lung Cancer in African Americans Yi Xiao COH
  • First Name: Xiaoke
    Last Name: Zou
    Affiliation: COH
  • First Name: Calvin
    Last Name: Tribby
    Affiliation: COH
  • First Name: Peter
    Last Name: Vien
    Affiliation: COH
  • First Name: Christina
    Last Name: Chang
    Affiliation: COH
  • First Name: Richard
    Last Name: Curley
    Affiliation: COH
  • First Name: Olutola
    Last Name: Akande
    Affiliation: COH
  • First Name: Melinda
    Last Name: Aldrich
    Affiliation: VUMC
  • First Name: Sophia
    Last Name: Wang
    Affiliation: COH
  • First Name: RIck
    Last Name: Kittles
    Affiliation: MSM
  • First Name: Kimlin
    Last Name: Ashing
    Affiliation: COH
  • First Name: Lennie
    Last Name: Wong
    Affiliation: COH
  • First Name: Marta
    Last Name: Jankowska
    Affiliation: COH
  • First Name: Tarik
    Last Name: Benmarhnia
    Affiliation: Scripps Institution of Oceanography
  • First Name: Loretta
    Last Name: Erhunmwunsee
    Affiliation: COH
Abstract_Submission.pdf No
Fri, 03/29/2024 - 13:18 Victoria Seewaldt victoria.seewaldt@me.com Session 2: Health Disparities in Lung Cancer The impact of diverse clinical trials personal on the diversity clinical trials participants Victoria Seewaldt City of Hope
  • First Name: Robert
    Last Name: Winn
    Affiliation: Massey Cancer Center
  • First Name: Augusto
    Last Name: Ochoa
    Affiliation: LSU Cancer center
Abstract_Submission.pdf No
Mon, 03/25/2024 - 13:09 Samrat Kundu skundu@mdanderson.org 2039093633 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Identifying resistant mechanisms to direct KRAS-inhibitors Samrat Kundu UT MD Anderson Cancer Center Abstract_Submission.pdf No
Mon, 03/18/2024 - 14:34 Ken Westover kenneth.westover@utsouthwestern.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies The On-Target MRTX1133 Resistance Mutation KRAS(R68S) Acts by Enhancing Lung Adenocarcinoma Cell Fitness Zhiwei Zhou UT Southwestern Medical Center
  • First Name: Dhiraj
    Last Name: Sinha
    Affiliation: UT Southwestern
  • First Name: Deekshi
    Last Name: Angira
    Affiliation: UT Southwestern
  • First Name: Xiaofang
    Last Name: Huo
    Affiliation: UT Southwestern
  • First Name: Michael
    Last Name: Peyton
    Affiliation: UT Southwestern
  • First Name: Kimberley
    Last Name: Avila
    Affiliation: UT Southwestern
  • First Name: John
    Last Name: Minna
    Affiliation: UT Southwestern
  • First Name: Ralf
    Last Name: Kittler
    Affiliation: UT Southwestern
  • First Name: Ken
    Last Name: Westover
    Affiliation: UT Southwestern
Abstract_Submission.pdf No
Thu, 03/14/2024 - 01:26 Alexandra Potter apotter8@mgh.harvard.edu 2538829777 Session 2: Health Disparities in Lung Cancer, Session 5: Early Detection and Screening The Impact of Removing the 15-year Since Quitting Smoking Criterion on Lung Cancer Screening Eligibility Alexandra Potter Massachusetts General Hospital
  • First Name: Priyanka
    Last Name: Senthil
    Affiliation: Massachusetts General Hospital
  • First Name: Quiana
    Last Name: Guo
    Affiliation: Massachusetts General Hospital
  • First Name: Arian
    Last Name: Mansur
    Affiliation: Massachusetts General Hospital
  • First Name: Uma
    Last Name: Sachdeva
    Affiliation: Massachusetts General Hospital
  • First Name: Hugh
    Last Name: Auchincloss
    Affiliation: Massachusetts General Hospital
  • First Name: Chi-Fu Jeffrey
    Last Name: Yang
    Affiliation: Massachusetts General Hospital
Abstract_Submission.pdf No
Wed, 03/13/2024 - 16:10 Luisa Solis Soto lmsolis@mdanderson.org 8327941469 Session 3: Immuno-oncology Comparison of Spatial transcriptomic platforms in lung adenocarcinoma tissue samples Nejla Ozirmak UT-MDACC
  • First Name: Max
    Last Name: Molina
    Affiliation: UT-MDACC
  • First Name: Sharia
    Last Name: Hernandez
    Affiliation: UT-MDACC
  • First Name: Alejandra
    Last Name: Serrano
    Affiliation: UT-MDACC
  • First Name: Wei
    Last Name: Lu
    Affiliation: UT-MDACC
  • First Name: Sean
    Last Name: Barnes
    Affiliation: UT-MDACC
  • First Name: Beatriz
    Last Name: Sanchez-Espiridion
    Affiliation: UT-MDACC
  • First Name: John
    Last Name: Heymach
    Affiliation: UT-MDACC
  • First Name: Jianjun
    Last Name: Zhang
    Affiliation: UT-MDACC
  • First Name: Boris
    Last Name: Sepesi
    Affiliation: UT-MDACC
  • First Name: Tina
    Last Name: Cascone
    Affiliation: UT-MDACC
  • First Name: Don
    Last Name: Gibbons
    Affiliation: UT-MDACC
  • First Name: Khaja
    Last Name: Khan
    Affiliation: UT-MDACC
  • First Name: Ignacio
    Last Name: Wistuba
    Affiliation: UT-MDACC
  • First Name: Cara
    Last Name: Haymaker
    Affiliation: UT-MDACC
  • First Name: Ken
    Last Name: Chen
    Affiliation: UT-MDACC
  • First Name: Luisa
    Last Name: Solis Soto
    Affiliation: UT-MDACC
Abstract_Submission.pdf Yes
Wed, 03/13/2024 - 08:39 Tianxiang Zhang tianxiang.zhang@yale.edu 2032857436 Session 3: Immuno-oncology Upregulated PLA2G10 in cancer impairs T-cell infiltration to dampen immunity Tianxiang Zhang Yale University
  • First Name: Weiwei
    Last Name: Yu
    Affiliation: Yale University
  • First Name: Xiaoxiao
    Last Name: Cheng
    Affiliation: Yale University
  • First Name: Jacky
    Last Name: Yeung
    Affiliation: Yale University
  • First Name: Viviana
    Last Name: Ahumada
    Affiliation: Yale University
  • First Name: Paul
    Last Name: Norris
    Affiliation: Sciex Demo Lab
  • First Name: Mackenzie
    Last Name: Pearson
    Affiliation: Sciex Demo Lab
  • First Name: Xuan
    Last Name: Yang
    Affiliation: Yale University
  • First Name: Ala
    Last Name: Nassar
    Affiliation: Yale University
  • First Name: Mathew
    Last Name: Vesely
    Affiliation: Yale University
  • First Name: Yu
    Last Name: Zhang
    Affiliation: Yale University
  • First Name: Jianping
    Last Name: Zhang
    Affiliation: Yale University
  • First Name: Lan
    Last Name: Ji
    Affiliation: Yale University
  • First Name: Dallas
    Last Name: Flies
    Affiliation: NextCure Inc.
  • First Name: Linda
    Last Name: Liu
    Affiliation: NextCure Inc.
  • First Name: Solomon
    Last Name: Langermann
    Affiliation: NextCure Inc.
  • First Name: William
    Last Name: LaRochelle
    Affiliation: Normunity Inc.
  • First Name: Rachel
    Last Name: Humphrey
    Affiliation: Normunity Inc.
  • First Name: Dejian
    Last Name: Zhao
    Affiliation: Yale University
  • First Name: Qiuyu
    Last Name: Zhang
    Affiliation: Yale University
  • First Name: Jindong
    Last Name: Zhang
    Affiliation: Yale University
  • First Name: Runxia
    Last Name: Gu
    Affiliation: Yale University
  • First Name: Kurt
    Last Name: Schalper
    Affiliation: Yale University
  • First Name: Miguel
    Last Name: Sanmamed
    Affiliation: University of Navarra
  • First Name: Lieping
    Last Name: Chen
    Affiliation: Yale University
Abstract_Submission.pdf No
Mon, 03/11/2024 - 17:58 Hye Mi Kim hyk61@pitt.edu 4122300387 Session 3: Immuno-oncology Development and Induction of Tertiary Lymphoid Structures in Lung Cancer for Improved Immunotherapeutics Hye Mi Kim University of Pittsburgh School of Medicine
  • First Name: Medard
    Last Name: Kaiza
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Ian
    Last Name: MacFawn
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Noor
    Last Name: Nader
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Elaine
    Last Name: Byrnes
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Alexandra
    Last Name: McDonough
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Caleb
    Last Name: Lampenfeld
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Sheryl
    Last Name: Kunning
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Asia
    Last Name: Williams
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Ashwin
    Last Name: Somasundaram
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Kelsey
    Last Name: Ertwine
    Affiliation: University of Pittsburgh School of Medicine
  • First Name: Stephen
    Last Name: Thorne
    Affiliation: KaliVir Immunotherapeutics
  • First Name: Laura
    Last Name: Stabile
    Affiliation: UPMC Hillman Cancer Center
  • First Name: Tullia
    Last Name: Bruno
    Affiliation: UPMC Hillman Cancer Center
Abstract_Submission.pdf No
Mon, 03/11/2024 - 15:50 Kristin Lastwika klastwik@fredhutch.org 206-667-5267 Session 4: Small Cell Lung Cancer Plasma Autoantibodies Identify Citrullinated Transferrin Receptor Neoepitopes in Small Cell Lung Cancer Kristin Lastwika FHCC
  • First Name: Sophia
    Last Name: Lauer
    Affiliation: FHCC
  • First Name: Francesca
    Last Name: Urselli
    Affiliation: FHCC
  • First Name: Justin
    Last Name: Taylor
    Affiliation: FHCC
  • First Name: Zachary
    Last Name: Samuels
    Affiliation: Hunter College
  • First Name: Brian
    Last Name: Zeglis
    Affiliation: Hunter College
  • First Name: McGarry
    Last Name: Houghton
    Affiliation: FHCC
  • First Name: Paul
    Last Name: Lampe
    Affiliation: FHCC
Abstract_Submission.pdf No
Mon, 03/11/2024 - 15:45 Jessica Konen jessica.marie.konen@emory.edu 4047783558 Session 3: Immuno-oncology, Session 6: Cancer Biology Loss of miR-29 as a mechanism of diminished anti-PD-1 response in lung cancer Jessica Konen Department of Hematology and Medical Oncology , Emory University
  • First Name: Lixia
    Last Name: Diao
    Affiliation: Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center
  • First Name: Jing
    Last Name: Wang
    Affiliation: Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center
  • First Name: Don
    Last Name: Gibbons
    Affiliation: Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center
Abstract_Submission.pdf No
Mon, 03/11/2024 - 15:01 Janet Freeman-Daily janet.f-d@comcast.net 253-606-2173 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Partnering with Patient Research Advocates Janet Freeman-Daily Fred Hutch SPORE (patient advocate)
  • First Name: Elda
    Last Name: Railey
    Affiliation: Research Advocacy Network
Abstract_Submission.pdf No
Mon, 03/11/2024 - 14:56 Florian Fintelmann fintelmann@mgh.harvard.edu 6178490063 Session 5: Early Detection and Screening Significance of image acquisition parameters for Sybil’s ability to predict future lung cancer risk on low-dose chest computed tomography Judit Simon MGH
  • First Name: Peter
    Last Name: Mikhael
    Affiliation: MIT
  • First Name: Alexander
    Last Name: Graur
    Affiliation: MGH
  • First Name: Regina
    Last Name: Barzilay
    Affiliation: MIT
  • First Name: Lecia
    Last Name: Sequist
    Affiliation: MGH
  • First Name: Florian
    Last Name: Fintelmann
    Affiliation: MGH
Abstract_Submission.pdf No
Mon, 03/11/2024 - 14:55 Elda Railey erailey@researchadvocacy.org 2146839937 Session 6: Cancer Biology Identifying Unique Challenges and Opportunities in Incorporating Patient Advocates into the Lung Cancer SPORE Program Elda Railey UTSWMC/MDACC Lung SPORe and Research Advocacy Network
  • First Name: John
    Last Name: Minna
    Affiliation: UTSWMC
Abstract_Submission.pdf No
Mon, 03/11/2024 - 14:54 Michael Grant michael.grant@yale.edu 2033147088 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Efficacy of afatinib in patients with tumors harboring the uncommon EGFR exon 19 deletion, L747_A750delinsP: a pooled analysis Michael Grant Yale University
  • First Name: Fernando
    Last Name: de Miguel
    Affiliation: Yale University
  • First Name: Michael
    Last Name: Kane
    Affiliation: Yale University
  • First Name: Yong
    Last Name: Kong
    Affiliation: Yale University
  • First Name: Jieling
    Last Name: Miao
    Affiliation: Fred Hutchinson Cancer Research Center
  • First Name: Mary
    Last Name: Redman
    Affiliation: Fred Hutchinson Cancer Research Center
  • First Name: Zenta
    Last Name: Walther
    Affiliation: Yale University
  • First Name: Katerina
    Last Name: Politi
    Affiliation: Yale University
  • First Name: Sarah
    Last Name: Goldberg
    Affiliation: Yale University
Abstract_Submission.pdf No
Mon, 03/11/2024 - 14:46 Austin Draycott austin.draycott@yale.edu 3475969754 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Dihydrouridine synthase 2 sustains levels of tRNACys to inhibit ferroptosis in lung cancer Austin Draycott Yale University
  • First Name: Matthew
    Last Name: Wang
    Affiliation: Yale University
  • First Name: Diana
    Last Name: Martínez Saucedo
    Affiliation: Yale University
  • First Name: Luisa
    Last Name: Escobar-Hoyos
    Affiliation: Yale University
  • First Name: Wendy
    Last Name: Gilbert
    Affiliation: Yale University
Abstract_Submission.pdf No
Mon, 03/11/2024 - 14:39 Tikvah Hayes TKHayes@mednet.ucla.edu Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Deep Mutational Scanning of EGFR Reveals Potential Domain-Specific TKI Sensitivities in Lung Cancer Tikvah Hayes UCLA Abstract_Submission.pdf No
Mon, 03/11/2024 - 14:27 Hyunmin Lee hyunmin.lee@yale.edu 7739800378 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies, Session 6: Cancer Biology LKB1-SIK axis controls SHMT-mediated antioxidant defense in KRAS-mutant lung cancer Hyunmin Lee Yale University
  • First Name: Constantinos
    Last Name: Chronis
    Affiliation: UIC
  • First Name: Kailong
    Last Name: Li
    Affiliation: Peking Univerisity
  • First Name: Brandon
    Last Name: Faubert
    Affiliation: University of Chicago
  • First Name: James
    Last Name: Kim
    Affiliation: UTSW
  • First Name: Jiyeon
    Last Name: Kim
    Affiliation: Yale University
Abstract_Submission.pdf No
Mon, 03/11/2024 - 14:17 Yichen Li yichen.li@yale.edu 2674085195 Session 1: Oncogene-driven lung cancers and resistance to targeted therapies Elucidate Epigenetic Mechanism underlying Tyrosine Kinase Inhibitors (TKIs) Resistance in Lung Adenocarcinoma (LUAD) Yichen Li Yale University
  • First Name: Andrew
    Last Name: Xiao
    Affiliation: Yale University
Abstract_Submission.pdf No
Mon, 03/11/2024 - 14:03 S. Lani Park lpark@cc.hawaii.edu Session 2: Health Disparities in Lung Cancer Racial and ethnic differences in the tumor immune microenvironment of lung adenocarcinomas Lenora Loo University of Hawaii Cancer Center
  • First Name: Alexandra
    Last Name: Binder
    Affiliation: University of Hawaii Cancer Center
  • First Name: Brenda
    Last Name: Hernandez
    Affiliation: University of Hawaii Cancer Center
  • First Name: Owen
    Last Name: Chan
    Affiliation: University of Hawaii Cancer Center
  • First Name: Lynne
    Last Name: Wilkens
    Affiliation: University of Hawaii Cancer Center
  • First Name: Kim
    Last Name: Siegmund
    Affiliation: Keck School of Medicine, University of Southern California
  • First Name: David
    Last Name: Conti
    Affiliation: Keck School of Medicine, University of Southern California
  • First Name: Loïc
    Last Name: Le Marchand
    Affiliation: University of Hawaii Cancer Center
  • First Name: S. Lani
    Last Name: Park
    Affiliation: University of Hawaii Cancer Center
Abstract_Submission.pdf Yes